Robbins Andrew R 4
4 · Cogent Biosciences, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+315,200→ 315,200 totalExercise: $10.17Exp: 2031-02-10→ Common Stock (315,200 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.